Español 
Cookie Settings 
Accessibility 
Rheumatology (Vasculitis)
Advanced Care for Pediatric Rheumatic Conditions
Rheumatology refers to inflammatory diseases that affect muscles, joints and connective tissues. These conditions often start with bone and joint pain. Often, a problem with the body's immune system causes it to attack its own cells. That is why many rheumatic conditions are called autoimmune. The pediatric rheumatology specialists at Arkansas Children's are specially trained to care for children with conditions more often associated with adults.
If your child has pediatric arthritis or another connective tissue disease, you may be worried about how to ease your child’s pain.
We treat many children with pediatric arthritis as well as children with a wide range of common and rare rheumatic conditions. At Arkansas Children's, our pediatric rheumatology doctors are experts in diagnosing and treating these conditions.
Our pediatric specialists at Arkansas Children’s provide advanced care for many conditions affecting children of all ages, including:
- Arthritis
- Autoimmune diseases
- Lupus
Possible Conditions
Meet the Team
The expert rheumatology doctors, nurses and physical therapists at Arkansas Children's are highly trained to treat a wide range of pediatric arthritis and rheumatic conditions. Our team provides your child with the most advanced treatment and is here to answer your questions.
Locations
Possible Treatments
Our team provides the most advanced care and many of our doctors, nurses and staff are actively involved in research to improve care outcomes and find new treatments for these often difficult-to-manage conditions.
Possible treatments include:
- Reducing and controlling symptoms using medicines such as steroids, anti-inflammatories or immunosuppressives
- Orthopedic surgery
- Physical therapy
Industry-Sponsored Studies
- Use of Humira in children with juvenile idiopathic arthritis.
A long-term, multi-center, longitudinal post-marketing, observational registry of Humira (Adalimumab) in children with active juvenile idiopathic arthritis (JIA): Sponsored by AbbVie (formerly Abbott Laboratories). - Safety and effectiveness of Certolizumab pegol in children with polyarticular juvenile idiopathic arthritis.
A multicenter, open-label study to assess the pharmacokinetics, safety and efficacy of Certolizumab pegol in children and adolescents with active polyarticular-course of JIA. Sponsored by UCB Biosciences, Inc. - Use of Abatacept in children with juvenile idiopathic arthritis.
An observational registry of Abatacept in patients with juvenile idiopathic arthritis. Sponsored by Bristol-Myers Squibb. - Study of Abatacept in children with active polyarticulare juvenile idiopathic arthritis.
A Phase 3, multi-center, open-label study to evaluate pharmacokinetics, efficacy and safety of Abatacept administered subcutaneously in children and adolescents with active polyarticular juvenile idiopathic arthritis. Sponsored by Bristol-Myers Squibb. - Study of Tofacitinib for children with polyarticulare juvenile idiopathic arthritis.
Efficacy, safety and tolerability of Tofacitinib for treatment of Poly JIA in children and adolescent subjects. Sponsored by Pfizer.
Investigator-Initiated Studies
These research studies were started by faculty members and doctors at Arkansas Children’s.
- Retrospective study on juvenile dermatomyositis (JDM) patients and risk of infections with biological medications. Approved in Sept 2016.
- Examination of the immunological profile of Sjogren's Syndrome patients. This is a collaborative study with the University of Florida at Gainesville. Approved in August 216. Recruiting patients.
Educational Resources
Use these resources to learn more about pediatric arthritis and other rheumatic diseases.
Arkansas Children's MyChart
Manage your child's medical information and connect with your Arkansas Children's medical team anytime online!
Log in to MyChart